A detailed history of International Biotechnology Trust PLC transactions in Uni Qure N.V. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 1,241,500 shares of QURE stock, worth $21.1 Million. This represents 2.83% of its overall portfolio holdings.

Number of Shares
1,241,500
Previous 15,500 7909.68%
Holding current value
$21.1 Million
Previous $177,000 4606.21%
% of portfolio
2.83%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$6.71 - $11.83 $8.23 Million - $14.5 Million
1,226,000 Added 7909.68%
1,241,500 $8.33 Million
Q2 2023

Aug 08, 2023

SELL
$11.12 - $22.2 $5.15 Million - $10.3 Million
-463,000 Reduced 96.76%
15,500 $177,000
Q1 2023

May 18, 2023

SELL
$18.7 - $23.07 $2.86 Million - $3.53 Million
-153,000 Reduced 24.23%
478,500 $9.64 Million
Q4 2022

Feb 01, 2023

BUY
$18.12 - $27.32 $1.58 Million - $2.38 Million
87,000 Added 15.98%
631,500 $14.3 Million
Q3 2022

Nov 08, 2022

BUY
$16.98 - $25.54 $9.1 Million - $13.7 Million
536,182 Added 6446.04%
544,500 $10.2 Million
Q2 2022

Aug 16, 2022

SELL
$13.15 - $20.45 $1.94 Million - $3.01 Million
-147,182 Reduced 94.65%
8,318 $447 Million
Q4 2021

Feb 15, 2022

SELL
$20.24 - $36.01 $540,286 - $961,250
-26,694 Reduced 14.65%
155,500 $3.23 Million
Q3 2021

Nov 12, 2021

SELL
$26.01 - $38.22 $3.47 Million - $5.09 Million
-133,306 Reduced 42.25%
182,194 $5.83 Million
Q2 2021

Aug 11, 2021

BUY
$29.97 - $37.17 $1 Million - $1.24 Million
33,466 Added 11.87%
315,500 $9.71 Million
Q1 2021

May 17, 2021

BUY
$29.24 - $42.03 $7.44 Million - $10.7 Million
254,534 Added 925.58%
282,034 $9.49 Million
Q1 2020

May 18, 2020

BUY
$40.01 - $73.97 $560,140 - $1.04 Million
14,000 Added 103.7%
27,500 $1.29 Million
Q4 2019

May 18, 2020

SELL
$37.13 - $74.62 $519,820 - $1.04 Million
-14,000 Reduced 50.91%
13,500 $967,000
Q2 2019

Aug 14, 2019

BUY
$52.76 - $82.19 $1.45 Million - $2.26 Million
27,500 New
27,500 $2.15 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $793M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.